1351 / 1481
After
conservative
surgery:
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2011 Nov 12;378(9804):1707-
16
To decrease mortality:
To decrease local
recurrences
:
WHY DO WE USE ADJUVANT RT IN
BREAST CANCER PATIENTS? (i)